Botulinum Toxin Market at a CAGR of 7.6% from 2018 to 2030

Global Botulinum Toxin Market – Snapshot

The global botulinum toxin market was valued at US$ 4,527.0 Mn in 2017 and is projected to reach US$ 8,718.7 Mn by 2026, expanding at a CAGR of 7.6% from 2018 to 2026. Increase in the prevalence of spasticity and cervical dystonia and the number of cases of migraine is expected to drive the botulinum toxin market during the forecast period. Surge in the rate of adoption of non-surgical botulinum toxin procedures, due to their noninvasive or minimally invasive nature, is boosting botulinum toxin market. Rise in the number of worldwide geriatric population and incidences of esthetic issues, such as crow’s foot and lateral canthal lines, is a key factor that is anticipated to propel the botulinum toxin market during the forecast period. However, lack of awareness regarding the advancements in non-surgical esthetic and therapeutic procedures is a major factors hampering revenue generation in the global botulinum toxin market.

Get the sample copy of report@ https://qyresearchmedical.com/sample/111974

The global botulinum toxin market has been segmented into product type, application, and region. In terms of product type, the market has been classified into botulinum toxin type A and botulinum toxin type B. The botulinum toxin type A segment held a prominent share of the global botulinum toxin market in 2017. Increase in prevalence of cervical dystonia, spasticity, glabellar lines, and crow’s foot and rise in the use of botulinum toxin type A are key factors driving the market. The botulinum toxin type B segment is expected to expand at a considerable CAGR during the forecast period. Advantages of botulinum toxin type B, such as faster onset of action and faster recovery time, and introduction of new and improved type B products in the market for new indications are major factors propelling the segment. Based on application, the global botulinum toxin market has been segregated into esthetic and therapeutics. The therapeutics segment dominated the global botulinum toxin market in 2017, owing to global rise in the cases of migraine and increase in the demand for non-surgical therapeutic procedure, which is noninvasive or minimally invasive in nature. The esthetic segment is anticipated to expand at a higher CAGR during the forecast period, owing to the increase in prevalence of lateral canthal lines and face wrinkles.

Based on region, the global botulinum toxin market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global botulinum toxin market in 2017, owing to the rise in awareness level regarding non-surgical esthetic and therapeutic procedures. The botulinum toxin market in North America is expected to maintain its dominant position in the global market during the forecast period. The botulinum toxin market in Europe is expected to expand during the forecast period, due to increase in geriatric population. The market in Asia Pacific is projected to expand at a comparatively higher CAGR during the forecast period, owing to the rise in adoption of non-surgical botulinum toxin procedures by the geriatric population and favorable government regulations.

Prominent players operating in the global botulinum toxin market include Allergan, Inc., Ipsen Group, Merz Pharma GmbH & Co. KGaA, Medytox, Inc., US Worldmed, LLC, Galderma, Metabiologics, Inc. (US), Lanzhou Institute of Biological Products Co. Ltd. and Revance Therapeutics, Inc. Allergan, Inc., Ipsen Group, and Merz Pharma GmbH & Co. KGaA are the prominent global market players in the botulinum toxin market. Allergan, Inc. has strong regional presence, either direct or through subsidiaries, distributors, and partnerships. Extensive research & development, international presence, robust marketing, and product reliability, provide the company, an upper hand over its competitors.

View full report@ https://qyresearchmedical.com/report/botulinum-toxin-market-product-type-botulinum-toxin-type-a-and-botulinum-toxin-type-b-application-aesthetic-therapeutics-global-industry-analysis-size-share-growth-trends-and-forecast-2018-2030/111974

Next-Generation Sequencing Technologies Bolster Botulinum Toxin Market

There has been some fascinating research in utilizing the biologic and pharmacological properties of botulinum toxin (BT) in medical sciences. Amusingly, it is the first biological toxin that has found its way to disease biology, opening up massive vistas of possibilities for healthcare companies. The use of next-generation sequencing technologies has helped propelled the strides in the botulinum toxin (BT) market. Among the various subtypes of BT, the use of subtype A for botulinum neurotoxin therapy has gained substantial attention among players. Researchers have been able to establish its remarkable safety and its potential for use in both injectable and oral form. This is a key driver for new avenues in the BT market. Botulinum neurotoxins (BoNT) is considered to be promising in numerous cosmetic and therapeutic interventions. A great deal of the progress has been fuelled by growing understanding of the pharmacology of BoNT. Some of the avenues where market players see potential revenue streams from the use of BT injections are in facial rejuvenation, in treating primary axillary hyperhidrosis, and hemimasticatory spasm. One of the promising therapeutic areas where BT is showing vast potential is being used as a therapeutic alternative for spasticity management which also includes poststroke spasticity.

The Covid-19 pandemic has been cause of substantial morbidity and mortality in worldwide populations. Recently emergent variants have caused havoc in some regions of the world. Policy makers in collaboration with industry players are keen on consolidating the logistics and supply chain of vaccine development to distribution to the last mile. Vaccine developers have been benefitting from favorable regulatory outlook. A recent case in point is approval of an array of vaccines. A great deal of the efforts in developing promising vaccine candidates for SARS-CoV-2 has been cemented by valuable learnings scientists and vaccine manufacturers have gained from SARS-CoV and MERS-CoV. The success that some nations have achieved in vaccinating people across different age groups has boosted consumer sentiment and is expected to bolster macroeconomic fundamentals.

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111974/2900

The global botulinum toxin market has been segmented as follows:

Product Type

  • Botulinum Toxin Type A
  • Botulinum Toxin Type B

Application

  • Aesthetic
  • Therapeutics

Region

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • Japan
  • China
  • India
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

TABLE OF CONTENT

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Botulinum Toxin Market

4. Market Overview
4.1. Introduction
4.1.1. by Product Type Definition
4.1.2. Market Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.1.1. Increasing demand for minimally invasive and non-invasive aesthetic and therapeutic procedures
4.3.1.2. Increase in prevalence of spasticity and cervical dystonia
4.3.1.3. Increasing number of products approval and new product launch in different region
4.3.1.4. Rising awareness regarding botulinum toxin procedures in the geriatric population worldwide
4.3.2. Restraints
4.3.2.1. Short time results and repetitive nature of aesthetic and therapeutic procedures
4.3.2.2. High cost of procedures and unavailability of reimbursement policies
4.3.3. Opportunities
4.3.3.1. Use of botulinum toxin products for the treatment of migraine and over sweating
4.3.3.2. Numerous products in phase III and above clinical trials for various disease conditions
4.4. Global Botulinum Toxin Market Analysis and Forecast, 2016–2026
4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights
5.1. Price Comparison Analysis (2017)
5.2. Pipeline Analysis
5.3. Launch and Patent Expiry – Snapshot
5.4. Key Trends
5.4.1. Increasing use of botulinum toxin aesthetic treatments by men
5.4.2. New and improved approaches regarding formulation types and delivery of botulinum toxin products

6. Global Botulinum Toxin Market Analysis and Forecast, by Product Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Global Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
6.3.1. Botulinum Toxin Type A
6.3.2. Botulinum Toxin Type B
6.4. Market Attractiveness by Product Type

7. Global Botulinum Toxin Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Global Botulinum Toxin Market Value Forecast, by Application, 2016–2026
7.3.1. Aesthetic
7.3.2. Therapeutics
7.4. Global Botulinum Toxin Market Attractiveness, by Application

8. Global Botulinum Toxin Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Global Botulinum Toxin Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Global Botulinum Toxin Market Attractiveness, by Region

9. North America Botulinum Toxin Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. North America Botulinum Toxin Market Value Forecast, by Product Type, 2016–2026
9.2.1. Botulinum Toxin Type A
9.2.2. Botulinum Toxin Type B
9.3. North America Botulinum Toxin Market Value Forecast, by Application, 2016–2026
9.3.1. Aesthetic
9.3.2. Therapeutics
9.4. North America Botulinum Toxin Market Value Forecast, by Country, 2016–2026
9.4.1. U.S.
9.4.2. Canada
9.5. North America Botulinum Toxin Market Attractiveness Analysis
9.5.1. By Product Type
9.5.2. By Application
9.5.3. By Country

10. Europe Botulinum Toxin Market Analysis and Forecast

……

Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111974/2900

You can place an order or ask any questions, please feel free to contact sales@qyresearchmedical.com | +1 9197 992 333

About Us

QYResearch Medical, focuses on custom research, management consulting, IPO consulting, industry chain research, and data base & seminar services. The company owns large basic databases (such as National Bureau of Statistics Database, Customs Import and Export Database, Industry Association Database, etc.), expert resources (including industry experts who own more than 10 years experiences on marketing or R&D in industries of healthcare services, medical technology & devices, etc.), professional survey team (the team members obtained more than 3 years market survey experience and more than 2 years deep expert interview experience), and excellent data analysis team (SPSS statistics and PPT graphics process team).

QYResearch Medical has more than 4000 global well-known customers, covering more than 30 industries including pharmaceuticals, medical technology & devices, healthcare services etc. Company services cover one-stop solution as Data-Analysis-Suggestion-Consulting Implementation. Research regions cover China, US, EU, Asia, Middle East and Africa, South America, Australia, and other regions in the world.

For Latest Update Follow Us:

https://www.linkedin.com/company/qyresearch-medical/

https://www.facebook.com/QYResearch-Medical-108186514228917/

https://twitter.com/qyresearchmedi